Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-29,500
Closed -$70K 64
2018
Q3
$70K Sell
29,500
-7,600
-20% -$1.5M 0.11% 105
2018
Q2
$201K Sell
37,100
-20,000
-35% -$3.54M 0.31% 57
2018
Q1
$625K Buy
57,100
+23,600
+70% +$4.33M 0.43% 20
2017
Q4
$268K Buy
33,500
+23,500
+235% +$4.16M 0.19% 66
2017
Q3
$35K Buy
+10,000
New +$1.77M 0.02% 243

Other funds holding AMGN

TLP Group's AMGN Position: Q4 2018 in Review

TLP Group sold out of Amgen (AMGN) in Q4 2018, closing a stake of 6,334 shares — an estimated $1.31M sold.

TLP Group first reported a position in AMGN in Q1 2017 and held it in 6 quarters. The position peaked at $1.94M in Q1 2018. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • TLP Group reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 6,334 Amgen shares in Q4 2018, an estimated $1.31M.
  • TLP Group first reported a position in Amgen in Q1 2017 and held it in 6 quarters.
  • TLP Group's Amgen position peaked at $1.94M in Q1 2018.
  • 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.